Attached files
| file | filename |
|---|---|
| EX-32.1 - CERTIFICATION - Cannabics Pharmaceuticals Inc. | cannabics_ex3201.htm |
| 10-Q - FORM 10-Q - Cannabics Pharmaceuticals Inc. | cannabics_10q-053120.htm |
| EX-31.2 - CERTIFICATION - Cannabics Pharmaceuticals Inc. | cannabics_ex3102.htm |
| EX-31.1 - CERTIFICATION - Cannabics Pharmaceuticals Inc. | cannabics_ex3101.htm |
Exhibit 32.2
CERTIFICATION OF
PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
In connection with this Quarterly Report of CANNABICS PHARMACEUTICALS INC. (the “Company”) on Form 10-Q for the quarter ending May 31, 2020, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Uri Ben Or, Chief Financial Officer (Principal Financial Officer) of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | Such Quarterly Report on Form 10-Q for the quarter ending May 31, 2020, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in such Quarterly Report on Form 10-Q for the quarter ending May 31, 2020, fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: July 14, 2020 | By: | /s/ Uri Ben Or | |
| Uri Ben Or | |||
|
Chief Financial Officer CANNABICS PHARMACEUTICALS INC. |
|||